www.fdanews.com/articles/157237-armagen-receives-u-s-orphan-designation-for-agt-182

Armagen Receives U.S. Orphan Designation for AGT-182

July 19, 2013

Armagen has received the FDA’s orphan drug designation for its drug AGT-182 to treat Hunter Syndrome, an X-linked genetic lysosomal storage disease.
Yahoo! Finance